The university’s Biodiscovery Institute (BDI) has published a brochure highlighting advances in shaping the future of health and biotechnology. 

The BDI is a £100 million world-leading hub of interdisciplinary research, accommodating 85 research groups and bringing together 850 researchers from the schools of Chemistry, Life Sciences, Medicine, Pharmacy, Veterinary Medicine and Science and the Faculty of Engineering.  

The institute (formerly the Centre for Biomolecular Sciences) has leveraged £300 million in funding since 2014 and later this year will be celebrating its 20th anniversary, with an international showcase in 2024 to mark this milestone. 

Its new brochure highlights how research in biotechnology is improving human health through new drug discovery, advanced materials for healthcare and better understanding of disease.  

Recent successes include establishing a £4m Nottingham Ovarian Cancer Research Centre and the £23.4 million renewal of the  National Biofilms Innovation Centre, which combines expertise from academia (Nottingham, Edinburgh, Liverpool, Southampton) with 200 industrial partners. 

The brochure also provides a directory of the BDI’s advanced facilities as well as the specialised research areas and techniques available from principal investigators across six multidisciplinary research themes. 

Bringing together researchers from a diverse range of disciplines has made developing a supportive environment and positive research culture a key aim of the BDI.  

Developments in this area have included Project Period, the provision of free sanitary products throughout the BDI which has now been taken up university-wide, and the empowerment of the early career researchers, which has been recognised by the University of Nottingham Tri Campus Awards 2023’s Team Award for Commitment to Enhancing the Research Culture and Environment. 

Find out more about the Biodiscovery Institute and view its 2023 brochure.